Sheri Smith

858 total citations
10 papers, 651 citations indexed

About

Sheri Smith is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, Sheri Smith has authored 10 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Sheri Smith's work include Neuroscience and Neuropharmacology Research (5 papers), Amino Acid Enzymes and Metabolism (3 papers) and Receptor Mechanisms and Signaling (3 papers). Sheri Smith is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Amino Acid Enzymes and Metabolism (3 papers) and Receptor Mechanisms and Signaling (3 papers). Sheri Smith collaborates with scholars based in United States. Sheri Smith's co-authors include Cyrille Sur, Wei Lemaire, David L. Williams, Philip R. Tiller, Craig W. Lindsley, Gene G. Kinney, Mark E. Duggan, Julie A. O’Brien, Maryann Burno and P. Jeffrey Conn and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Drug Metabolism and Disposition.

In The Last Decade

Sheri Smith

10 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheri Smith United States 9 404 358 132 72 70 10 651
Noriko Simorowski United States 11 687 1.7× 704 2.0× 123 0.9× 43 0.6× 35 0.5× 13 925
Matthew Szapacs United States 15 329 0.8× 125 0.3× 140 1.1× 33 0.5× 26 0.4× 28 729
Lars J. S. Knutsen Denmark 17 603 1.5× 665 1.9× 92 0.7× 259 3.6× 45 0.6× 36 1.2k
Kay L. Saywell United Kingdom 12 349 0.9× 375 1.0× 46 0.3× 203 2.8× 44 0.6× 18 770
Frank Brown United Kingdom 15 399 1.0× 187 0.5× 67 0.5× 357 5.0× 145 2.1× 30 1.0k
Klaus P. Bøgesø Denmark 16 392 1.0× 398 1.1× 65 0.5× 266 3.7× 30 0.4× 31 808
Stéphan Schann France 15 436 1.1× 372 1.0× 25 0.2× 91 1.3× 25 0.4× 26 643
Stephen D. Hurt United States 10 351 0.9× 366 1.0× 45 0.3× 65 0.9× 38 0.5× 19 526
François Bischoff Belgium 13 365 0.9× 345 1.0× 37 0.3× 170 2.4× 24 0.3× 22 681
Theodosia Vallianatou Sweden 19 631 1.6× 91 0.3× 586 4.4× 45 0.6× 14 0.2× 35 1.1k

Countries citing papers authored by Sheri Smith

Since Specialization
Citations

This map shows the geographic impact of Sheri Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheri Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheri Smith more than expected).

Fields of papers citing papers by Sheri Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheri Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheri Smith. The network helps show where Sheri Smith may publish in the future.

Co-authorship network of co-authors of Sheri Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Sheri Smith. A scholar is included among the top collaborators of Sheri Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheri Smith. Sheri Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Eikel, Daniel, Marissa Vavrek, Sheri Smith, et al.. (2011). Liquid extraction surface analysis mass spectrometry (LESA‐MS) as a novel profiling tool for drug distribution and metabolism analysis: the terfenadine example. Rapid Communications in Mass Spectrometry. 25(23). 3587–3596. 130 indexed citations
2.
Zhao, Zhijian, William Leister, Julie A. O’Brien, et al.. (2009). Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(5). 1488–1491. 16 indexed citations
3.
Wolkenberg, S. E., Zhijian Zhao, David D. Wisnoski, et al.. (2009). Discovery of GlyT1 inhibitors with improved pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 19(5). 1492–1495. 15 indexed citations
4.
Zhao, Zhijian, Julie A. O’Brien, Wei Lemaire, et al.. (2006). Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides. Bioorganic & Medicinal Chemistry Letters. 16(23). 5968–5972. 12 indexed citations
5.
6.
Kinney, Gene G., Julie A. O’Brien, Wei Lemaire, et al.. (2005). A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models. Journal of Pharmacology and Experimental Therapeutics. 313(1). 199–206. 229 indexed citations
7.
Lindsley, Craig W., David D. Wisnoski, William Leister, et al.. (2004). Discovery of Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 5 from a Series of N-(1,3-Diphenyl-1H- pyrazol-5-yl)benzamides That Potentiate Receptor Function in Vivo. Journal of Medicinal Chemistry. 47(24). 5825–5828. 139 indexed citations
8.
Fraley, Mark E., Kenneth L. Arrington, Carolyn A. Buser, et al.. (2003). Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(2). 351–355. 43 indexed citations
9.
Balani, Suresh K., Mark E. Goldman, S Varga, et al.. (1993). Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.. Drug Metabolism and Disposition. 21(4). 598–604. 2 indexed citations
10.
Saari, Walfred S., et al.. (1990). Cyclization-activated prodrugs. Basic esters of 5-bromo-2'-deoxyuridine. Journal of Medicinal Chemistry. 33(9). 2590–2595. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026